SNDL
Price
$1.22
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
Capitalization
342.11M
29 days until earnings call
Intraday BUY SELL Signals
ZTS
Price
$74.81
Change
+$1.73 (+2.37%)
Updated
Oct 9 closing price
Capitalization
29.52B
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SNDL vs ZTS

SNDL vs ZTS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SNDL vs. ZTS commentary
Oct 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNDL is a Hold and ZTS is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
SNDL vs ZTS: Fundamental Ratings
SNDL
ZTS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9118
PRICE GROWTH RATING
1..100
7862
P/E GROWTH RATING
1..100
8693
SEASONALITY SCORE
1..100
45n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (10) in the Pharmaceuticals Generic industry is somewhat better than the same rating for SNDL (43) in the null industry. This means that ZTS’s stock grew somewhat faster than SNDL’s over the last 12 months.

ZTS's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as SNDL (100) in the null industry. This means that ZTS’s stock grew similarly to SNDL’s over the last 12 months.

ZTS's SMR Rating (18) in the Pharmaceuticals Generic industry is significantly better than the same rating for SNDL (91) in the null industry. This means that ZTS’s stock grew significantly faster than SNDL’s over the last 12 months.

ZTS's Price Growth Rating (62) in the Pharmaceuticals Generic industry is in the same range as SNDL (78) in the null industry. This means that ZTS’s stock grew similarly to SNDL’s over the last 12 months.

SNDL's P/E Growth Rating (86) in the null industry is in the same range as ZTS (93) in the Pharmaceuticals Generic industry. This means that SNDL’s stock grew similarly to ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNDLZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
52%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
51%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
51%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 11 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
67%
COMPARISON
Comparison
Oct 12, 2026
Stock price -- (SNDL: $1.22 vs. ZTS: $74.81)
Brand notoriety: SNDL: Not notable vs. ZTS: Notable
SNDL represents the Beverages: Alcoholic, while ZTS is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SNDL: 59% vs. ZTS: 54%
Market capitalization -- SNDL: $342.11M vs. ZTS: $29.52B
SNDL [@Beverages: Alcoholic] is valued at $342.11M. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $29.52B. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $3.75K to $14.38T. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Beverages: Alcoholic] industry is $5.4B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNDL’s FA Score shows that 0 FA rating(s) are green while ZTS’s FA Score has 2 green FA rating(s).

  • SNDL’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, ZTS is a better buy in the long-term than SNDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNDL’s TA Score shows that 3 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • SNDL’s TA Score: 3 bullish, 6 bearish.
  • ZTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than SNDL.

Price Growth

SNDL (@Beverages: Alcoholic) experienced а -1.61% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +7.35% for the same time period.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -1.08%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was -17.74%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.50%. For the same industry, the average monthly price growth was -2.73%, and the average quarterly price growth was +25.38%.

Reported Earning Dates

SNDL is expected to report earnings on Nov 10, 2026.

ZTS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Beverages: Alcoholic (-1.08% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

@Pharmaceuticals: Generic (+0.50% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
SNDL
Daily Signal:
Gain/Loss:
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE3.750.23
+6.53%
Inspired Entertainment
NXAT0.650.02
+3.59%
Nexus Advanced Technologies Inc
EXTR24.190.01
+0.04%
Extreme Networks
BAK1.82N/A
N/A
Braskem SA
EMA45.66-0.19
-0.41%
Emera Inc

SNDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDL has been closely correlated with CGC. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNDL jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDL
1D Price
Change %
SNDL100%
N/A
CGC - SNDL
77%
Closely correlated
-2.33%
TLRY - SNDL
76%
Closely correlated
-1.39%
CRON - SNDL
73%
Closely correlated
+0.31%
OGI - SNDL
68%
Closely correlated
+0.86%
ACB - SNDL
65%
Loosely correlated
+1.35%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with PAHC. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+2.37%
PAHC - ZTS
58%
Loosely correlated
+2.41%
ELAN - ZTS
44%
Loosely correlated
+1.69%
AMPH - ZTS
36%
Loosely correlated
+3.14%
HLN - ZTS
33%
Loosely correlated
+0.65%
SNDL - ZTS
33%
Loosely correlated
N/A
More